Mechanical ventilation

Global Respiratory Monitoring Devices Market 2020-2024: Market Analysis, Drivers, Restraints, Opportunities, and Threats - Technavio

Retrieved on: 
Wednesday, November 11, 2020
Medical devices, Health, Medical specialties, Medicine, Clinical medicine, Intensive care medicine, Medical terminology, Anesthesia, Cardiology, Medical monitoring, Pulse oximetry, Mechanical ventilation, Monitoring, Chronic condition

The respiratory monitoring devices market is expected to grow by USD 1.77 billion, progressing at a CAGR of over 9% during the forecast period.

Key Points: 
  • The respiratory monitoring devices market is expected to grow by USD 1.77 billion, progressing at a CAGR of over 9% during the forecast period.
  • View the full release here: https://www.businesswire.com/news/home/20201111005546/en/
    Technavio has announced its latest market research report titled Global Respiratory Monitoring Devices Market 2020-2024 (Graphic: Business Wire)
    The increasing prevalence of chronic respiratory diseases is one of the major factors propelling market growth.
  • Based on the product, the pulse oximetry segment is expected to post significant growth during the forecast period.
  • North America and Canada are the key markets for Respiratory Monitoring Devices in North America.

Mechanical Ventilator Market Size is Estimated To Reach USD 12.54 Billion By 2027 - Valuates Reports

Retrieved on: 
Friday, November 6, 2020
Medical specialties, Respiratory therapy, Medicine, Health care, Ventilator, Mechanical ventilation

BANGALORE, India, Nov. 6, 2020 /PRNewswire/ -- A new Mechanical Ventilator Market Research Report published on Valuates Reports in Medical Devices & Equipment Category.

Key Points: 
  • BANGALORE, India, Nov. 6, 2020 /PRNewswire/ -- A new Mechanical Ventilator Market Research Report published on Valuates Reports in Medical Devices & Equipment Category.
  • The global mechanical ventilator market size was valued at USD 2.99 Billion in 2019 and is estimated to reach USD 12.54 Billion by 2027 at a CAGR of 16.5% from 2020 to 2027.
  • The exponential rise in COVID-19 cases worldwide requires long-term and short-term respiratory assistance, thereby increasing the mechanical ventilator market size.
  • One of the main drivers of the mechanical ventilator market size is the rise of the geriatric population vulnerable to respiratory emergencies.

Mechanical Ventilator Market Size is Estimated To Reach USD 12.54 Billion By 2027 - Valuates Reports

Retrieved on: 
Friday, November 6, 2020
Medical specialties, Respiratory therapy, Medicine, Health care, Ventilator, Mechanical ventilation

BANGALORE, India, Nov. 6, 2020 /PRNewswire/ -- A new Mechanical Ventilator Market Research Report published on Valuates Reports in Medical Devices & Equipment Category.

Key Points: 
  • BANGALORE, India, Nov. 6, 2020 /PRNewswire/ -- A new Mechanical Ventilator Market Research Report published on Valuates Reports in Medical Devices & Equipment Category.
  • The global mechanical ventilator market size was valued at USD 2.99 Billion in 2019 and is estimated to reach USD 12.54 Billion by 2027 at a CAGR of 16.5% from 2020 to 2027.
  • The exponential rise in COVID-19 cases worldwide requires long-term and short-term respiratory assistance, thereby increasing the mechanical ventilator market size.
  • One of the main drivers of the mechanical ventilator market size is the rise of the geriatric population vulnerable to respiratory emergencies.

EQS-News: Relief Therapeutics and NeuroRx announce continuation of RLF-100(TM) trial for treatment of COVID-19 Respiratory Failure: Trial is on track to complete enrollment in 2020

Retrieved on: 
Thursday, November 5, 2020
Medical specialties, Clinical medicine, Medicine, Intensive care medicine, Mechanical ventilation, Respiratory therapy, Medical emergencies, Acute respiratory distress syndrome, Respiratory physiology, Respiratory failure, Non-invasive ventilation, Respiratory distress syndrome

RLF-100(TM) was granted FDA Fast Track designation in June 2020 and was previously granted Orphan Drug Designation for the treatment of Acute Respiratory Distress Syndrome.

Key Points: 
  • RLF-100(TM) was granted FDA Fast Track designation in June 2020 and was previously granted Orphan Drug Designation for the treatment of Acute Respiratory Distress Syndrome.
  • All patients were hospitalized in intensive care units with respiratory failure treated by mechanical ventilation, non-invasive ventilation, or high-flow nasal oxygen.
  • At current rates of enrollment (which may change as infection rates change) the study is expected to complete enrollment by mid-December and yield top-line data in January 2021.
  • Disclaimer: This communication expressly or implicitly contains certain forward-looking statements concerning RELIEF THERAPEUTICS Holding AG, NeuroRx, Inc. and their businesses.

NeuroRx and Relief Therapeutics announce continuation of RLF-100™ trial for treatment of COVID-19 Respiratory Failure: Trial is on track to complete enrollment in 2020

Retrieved on: 
Thursday, November 5, 2020
Medical specialties, Clinical medicine, Medicine, Intensive care medicine, Respiratory diseases, Mechanical ventilation, Respiratory therapy, Neonatology, Respiratory failure, Acute respiratory distress syndrome, Respiratory distress syndrome, Non-invasive ventilation

RLF-100 was granted FDA Fast Track designation in June 2020 and was previously granted Orphan Drug Designation for the treatment of Acute Respiratory Distress Syndrome.

Key Points: 
  • RLF-100 was granted FDA Fast Track designation in June 2020 and was previously granted Orphan Drug Designation for the treatment of Acute Respiratory Distress Syndrome.
  • All patients were hospitalized in intensive care units with respiratory failure treated by mechanical ventilation, non-invasive ventilation, or high-flow nasal oxygen.
  • At current rates of enrollment (which may change as infection rates change) the study is expected to complete enrollment by mid-December and yield top-line data in January 2021.
  • Disclaimer: This communication expressly or implicitly contains certain forward-looking statements concerning RELIEF THERAPEUTICS Holding AG, NeuroRx, Inc. and their businesses.

Philips expands its home care portfolio for COPD patients with first-of-its-kind non-invasive ventilator

Retrieved on: 
Wednesday, November 4, 2020
Medical specialties, Medicine, Clinical medicine, Mechanical ventilation, Respiratory therapy, Non-invasive ventilation, Chronic obstructive pulmonary disease, Respiratory therapist, Respiratory disease, Ventilator, Philips, COPD: Journal of Chronic Obstructive Pulmonary Disease

With the introduction of this non-invasive ventilator, Philips extends its homecare solutions with a new ventilation therapy feature for chronic obstructive pulmonary disease (COPD) patients to breathe easier.

Key Points: 
  • With the introduction of this non-invasive ventilator, Philips extends its homecare solutions with a new ventilation therapy feature for chronic obstructive pulmonary disease (COPD) patients to breathe easier.
  • EFL often goes undetected, meaning patients dont receive the care they need to improve their disease, said Eli Diacopoulos, Respiratory Care Business Leader at Philips.
  • Clinicians can now detect EFL in hypercapnic COPD patients at the point of care, ensure personalized patient treatment at home and monitor care remotely.
  • When prescribed and used in the home, the BiPAP A40 EFL connects to Philips Care Orchestrator cloud-based care management system.

Continuous Positive Airway Pressure (CPAP) Device Market to Reach US$ 4 Billion by 2026, Globally |CAGR: 9% | UnivDatos Market Insights

Retrieved on: 
Friday, October 30, 2020
Medicine, Clinical medicine, Medical specialties, Mechanical ventilation, Sleep disorders, Medical equipment, Intensive care medicine, Continuous positive airway pressure, Positive airway pressure, Sleep apnea, Obstructive sleep apnea, Mandibular advancement splint

"Continuous Positive Airway Pressure (CPAP) Device Market is expected to grow at a CAGR of 9% from 2021-2026 to reach US$ 4,151.2 million by 2026.

Key Points: 
  • "Continuous Positive Airway Pressure (CPAP) Device Market is expected to grow at a CAGR of 9% from 2021-2026 to reach US$ 4,151.2 million by 2026.
  • Continuous positive airway pressure therapy (CPAP) uses a device that makes it easier for a person with obstructive sleep apnea (OSA) to breathe during sleep.
  • Global Continuous Positive Airway Pressure (CPAP) Device Market report is studied thoroughly with several aspects that would help stakeholders in making their decisions more curated.
  • Continuous Positive Airway Pressure (CPAP) Device Market Geographical Segmentation Includes:
    North America (the United States, Canada and Rest of North America)
    Based on the estimation, North America dominated the continuous positive airway pressure (CPAP) device market with almost 35% of the market revenue in 2019.

Continuous Positive Airway Pressure (CPAP) Device Market to Reach US$ 4 Billion by 2026, Globally |CAGR: 9% | UnivDatos Market Insights

Retrieved on: 
Friday, October 30, 2020
Medicine, Clinical medicine, Medical specialties, Mechanical ventilation, Sleep disorders, Medical equipment, Intensive care medicine, Continuous positive airway pressure, Positive airway pressure, Sleep apnea, Obstructive sleep apnea, Mandibular advancement splint

"Continuous Positive Airway Pressure (CPAP) Device Market is expected to grow at a CAGR of 9% from 2021-2026 to reach US$ 4,151.2 million by 2026.

Key Points: 
  • "Continuous Positive Airway Pressure (CPAP) Device Market is expected to grow at a CAGR of 9% from 2021-2026 to reach US$ 4,151.2 million by 2026.
  • Continuous positive airway pressure therapy (CPAP) uses a device that makes it easier for a person with obstructive sleep apnea (OSA) to breathe during sleep.
  • Global Continuous Positive Airway Pressure (CPAP) Device Market report is studied thoroughly with several aspects that would help stakeholders in making their decisions more curated.
  • Continuous Positive Airway Pressure (CPAP) Device Market Geographical Segmentation Includes:
    North America (the United States, Canada and Rest of North America)
    Based on the estimation, North America dominated the continuous positive airway pressure (CPAP) device market with almost 35% of the market revenue in 2019.

The outbreak of the COVID-19 pandemic and growing prevalence of respiratory diseases to propel growth of the ventilators market by 2021 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Friday, October 30, 2020
Medical specialties, Health care, Respiratory therapy, Medicine, Ventilator, Mechanical ventilation, Intensive care medicine, Hospital departments

Growth in this segment is attributed due to the rising number of intensive care beds equipped with ventilators.

Key Points: 
  • Growth in this segment is attributed due to the rising number of intensive care beds equipped with ventilators.
  • The ICU ventilators segment is further sub-segmented into high-end ICU ventilators, mid-end ICU ventilators, and basic ICU ventilators.
  • On the basis of type, the adult/pediatric ventilators segment is expected to account for the largest share of the ventilators market in 2019
    Based on type, the market for ventilators is segmented into adult/pediatric ventilators and neonatal/infant ventilators.
  • Growth in the invasive ventilation market can be attributed to increasing severity in COVID-19 patients and the rising prevalence of respiratory diseases, neurological diseases, and sleeping disorders.

The outbreak of the COVID-19 pandemic and growing prevalence of respiratory diseases to propel growth of the ventilators market by 2021 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Friday, October 30, 2020
Medical specialties, Health care, Respiratory therapy, Medicine, Ventilator, Mechanical ventilation, Intensive care medicine, Hospital departments

Growth in this segment is attributed due to the rising number of intensive care beds equipped with ventilators.

Key Points: 
  • Growth in this segment is attributed due to the rising number of intensive care beds equipped with ventilators.
  • The ICU ventilators segment is further sub-segmented into high-end ICU ventilators, mid-end ICU ventilators, and basic ICU ventilators.
  • On the basis of type, the adult/pediatric ventilators segment is expected to account for the largest share of the ventilators market in 2019
    Based on type, the market for ventilators is segmented into adult/pediatric ventilators and neonatal/infant ventilators.
  • Growth in the invasive ventilation market can be attributed to increasing severity in COVID-19 patients and the rising prevalence of respiratory diseases, neurological diseases, and sleeping disorders.